Guillain-Barré syndrome, a relatively uncommon neurological disorder, occurs when the immune system mistakenly targets the peripheral nervous system. The level of severity linked to this condition can vary drastically, ranging from mild muscular weakness to total paralysis. Despite ongoing research, the exact cause of Guillain-Barré syndrome remains elusive. Thankfully, this disorder can be effectively managed, although complete recovery may take a considerable amount of time.
Symptoms of Guillain-Barré Syndrome
When it comes to Guillain-Barré syndrome, the initial signs usually manifest as weakness and tingling sensations in the feet and legs. As the condition progresses, these sensations gradually spread to the upper body. However, in about 10% of cases, the symptoms may first appear in the arms or face. Alongside weakness and tingling, individuals with Guillain-Barré syndrome may experience a range of other symptoms.
Types of Guillain-Barré Syndrome
Guillain-Barré syndrome is no longer recognized as a single condition, but rather a group of several different types. The most common type in North America and Europe is known as acute inflammatory demyelinating polyradiculoneuropathy (AIDP). This type is characterized by weakness that starts in the lower body.
Another type of Guillain-Barré syndrome, called Miller Fisher syndrome, is more prevalent in Asia and less common in North America. It is distinguished by symptoms such as eye paralysis and difficulty walking.
In addition to AIDP and Miller Fisher syndrome, there are two other recognized types: acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN). These two types are more frequently observed in Mexico, Japan, and China.